‘Magic tables’ provide stimulation for memory care residents
By
Kimberly Bonvissuto
May 06, 2022
Table top gaming consoles — so-called magic tables — are taking off in memory care communities, providing an easy way to stimulate the brains of those with memory impairing diseases.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Argentum calls for continued industry self-regulation as association ramps up advocacy efforts
By
Kimberly Bonvissuto
Sep 14, 2021
PHOENIX—Argentum has spent the past 18 months elevating several priorities, with senior living industry advocacy rising to the top as a critical need during the pandemic amid changing federal and state...
Dementia-competent workforce, career advancement keys to improving Alzheimer’s care: Senate committee
By
Kimberly Bonvissuto
May 21, 2021
Developing a dementia-competent workforce and providing career advancement opportunities will help strengthen direct care workforce recruitment and retention, leading to a better quality of life for people...
Recommendations to reduce disparities in dementia care due in 2021
By
Kimberly Bonvissuto
Dec 09, 2020
Final recommendations on ways to reduce disparities in dementia, which were developed during a stakeholder roundtable sponsored by the Milken Institute Alliance to Improve Dementia Care, will be released...
Company can’t market cannabidiol products for Parkinson’s, Alzheimer’s, FDA and FTC say
By
Lois A. Bowers
Oct 23, 2019
A Florida company must stop marketing its unapproved cannabidiol products using unsubstantiated claims that the products treat Parkinson’s disease, Alzheimer’s disease and other conditions, the Food...